235 related articles for article (PubMed ID: 28122051)
1. Low Cytochrome Oxidase 1 Links Mitochondrial Dysfunction to Atherosclerosis in Mice and Pigs.
Holvoet P; Vanhaverbeke M; Geeraert B; De Keyzer D; Hulsmans M; Janssens S
PLoS One; 2017; 12(1):e0170307. PubMed ID: 28122051
[TBL] [Abstract][Full Text] [Related]
2. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
3. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
[TBL] [Abstract][Full Text] [Related]
4. Low cytochrome oxidase 4I1 links mitochondrial dysfunction to obesity and type 2 diabetes in humans and mice.
Van der Schueren B; Vangoitsenhoven R; Geeraert B; De Keyzer D; Hulsmans M; Lannoo M; Huber HJ; Mathieu C; Holvoet P
Int J Obes (Lond); 2015 Aug; 39(8):1254-63. PubMed ID: 25869607
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin restores superoxide dismutase expression and inhibits accumulation of oxidized LDL in the aortic arch of obese dyslipidemic mice.
Verreth W; De Keyzer D; Davey PC; Geeraert B; Mertens A; Herregods MC; Smith G; Desjardins F; Balligand JL; Holvoet P
Br J Pharmacol; 2007 Jun; 151(3):347-55. PubMed ID: 17384667
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.
Rahtu-Korpela L; Määttä J; Dimova EY; Hörkkö S; Gylling H; Walkinshaw G; Hakkola J; Kivirikko KI; Myllyharju J; Serpi R; Koivunen P
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):608-17. PubMed ID: 26848160
[TBL] [Abstract][Full Text] [Related]
7. Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.
Holvoet P
Verh K Acad Geneeskd Belg; 2008; 70(3):193-219. PubMed ID: 18669160
[TBL] [Abstract][Full Text] [Related]
8. Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells.
Roy Chowdhury SK; Sangle GV; Xie X; Stelmack GL; Halayko AJ; Shen GX
Am J Physiol Endocrinol Metab; 2010 Jan; 298(1):E89-98. PubMed ID: 19843872
[TBL] [Abstract][Full Text] [Related]
9. Effect of leptin treatment on mitochondrial function in obese leptin-deficient ob/ob mice.
Holmström MH; Tom RZ; Björnholm M; Garcia-Roves PM; Zierath JR
Metabolism; 2013 Sep; 62(9):1258-67. PubMed ID: 23664724
[TBL] [Abstract][Full Text] [Related]
10. Increased PAFAH and oxidized lipids are associated with inflammation and atherosclerosis in hypercholesterolemic pigs.
De Keyzer D; Karabina SA; Wei W; Geeraert B; Stengel D; Marsillach J; Camps J; Holvoet P; Ninio E
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2041-6. PubMed ID: 19797705
[TBL] [Abstract][Full Text] [Related]
11. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
[TBL] [Abstract][Full Text] [Related]
12. Glyoxalase 1 overexpression does not affect atherosclerotic lesion size and severity in ApoE-/- mice with or without diabetes.
Hanssen NM; Brouwers O; Gijbels MJ; Wouters K; Wijnands E; Cleutjens JP; De Mey JG; Miyata T; Biessen EA; Stehouwer CD; Schalkwijk CG
Cardiovasc Res; 2014 Oct; 104(1):160-70. PubMed ID: 25139743
[TBL] [Abstract][Full Text] [Related]
13. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
[TBL] [Abstract][Full Text] [Related]
14. Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.
Bojic LA; Burke AC; Chhoker SS; Telford DE; Sutherland BG; Edwards JY; Sawyez CG; Tirona RG; Yin H; Pickering JG; Huff MW
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):52-60. PubMed ID: 24158519
[TBL] [Abstract][Full Text] [Related]
15. LDL hypercholesterolemia is associated with accumulation of oxidized LDL, atherosclerotic plaque growth, and compensatory vessel enlargement in coronary arteries of miniature pigs.
Holvoet P; Theilmeier G; Shivalkar B; Flameng W; Collen D
Arterioscler Thromb Vasc Biol; 1998 Mar; 18(3):415-22. PubMed ID: 9514410
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis.
Waltmann MD; Basford JE; Konaniah ES; Weintraub NL; Hui DY
Biochim Biophys Acta; 2014 Sep; 1842(9):1395-405. PubMed ID: 24840660
[TBL] [Abstract][Full Text] [Related]
17. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
18. Effects of age, diet, and type 2 diabetes on the development and FDG uptake of atherosclerotic plaques.
Silvola JM; Saraste A; Laitinen I; Savisto N; Laine VJ; Heinonen SE; Ylä-Herttuala S; Saukko P; Nuutila P; Roivainen A; Knuuti J
JACC Cardiovasc Imaging; 2011 Dec; 4(12):1294-301. PubMed ID: 22172786
[TBL] [Abstract][Full Text] [Related]
19. [Peroxisome proliferator-activated receptor α/γ agonist tesaglitazar stabilizes atherosclerotic plaque in diabetic low density lipoprotein receptor knockout mice].
Zhang BC; Li XK; Che WL; Li WM; Hou L; Wei YD; Xu YW
Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):143-9. PubMed ID: 23710746
[TBL] [Abstract][Full Text] [Related]
20. Defective leptin-AMP-dependent kinase pathway induces nitric oxide release and contributes to mitochondrial dysfunction and obesity in ob/ob mice.
Finocchietto PV; Holod S; Barreyro F; Peralta JG; Alippe Y; Giovambattista A; Carreras MC; Poderoso JJ
Antioxid Redox Signal; 2011 Nov; 15(9):2395-406. PubMed ID: 21529143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
